期刊文献+

肠道T细胞淋巴瘤的研究现状与进展 被引量:4

Progress of intestinal T-cell lymphoma
下载PDF
导出
摘要 肠道T细胞淋巴瘤(ITCL)是一类起源于肠上皮内T淋巴细胞的恶性肿瘤,过去被称为"肠道恶性组织细胞增生症",近年来发现这一疾病的本质是ITCL。该病的临床表现复杂,病程进展迅猛,内镜和消化道钡餐检查很难确诊。由于ITCL临床少见,且易复发,对治疗的反应和预后极差,应引起临床医师的广泛重视。 Intestinal T-cell lymphoma,also known as "intestinal malignant histiocytosis",is derived from intraepithelial T-lymphocytes of intestine.Currently,its nature has been demonstrated to be a kind of intestinal T-cell lymphoma.The disease characteristic is complex clinical manifestation and rapid progress course of disease and difficult diagnosis with endoscopy and gastrointestinal barium meal examination.Because of its rarity,lack of characteristic manifestations,poor response to treatment,high frequency of relapse rate and poor prognosis.Hence,more attention should be paid on this disease.
作者 吴狄 顾康生
出处 《临床肿瘤学杂志》 CAS 2010年第12期1146-1149,共4页 Chinese Clinical Oncology
关键词 肠道T细胞淋巴瘤 诊断 治疗 预后 Intestine T-cell lymphoma Diagnosis Therapy Prognosis
  • 相关文献

参考文献29

  • 1Yin L,Chen CQ,Peng CH,et al.Primary small-bowel non-Hodgkin's lymphoma a study of clinical features,pathology,management and prognosis[J].J Int Med Res,2007,35:406-415.
  • 2Li B,Shi YK,He XH,et al.Primary non-Hodgkin lymphomas in the small and large intestine:clinicopathological characteristics and management of 40 patients[J].Int J Hematol,2008,87:375-381.
  • 3Hodges JR,Isaacson P,Smith CL,et al.Malignant histiocytosis of the intestine[J].Dig Dis Sci,1979,24(8):631-638.
  • 4Domizio P,Owen RA,Shepherd NA,et al.Primary lyrnphoma of the small intestine.A clinicopathological study of 119 cases[J].Am J Surg Pathol,1993,17:429-442.
  • 5Harris NL,Jafe ES,Stein H,et al.A revised European-American classification of lymphoid neoplasms:a proposal from the International Lymphoma Study Group[J].Blood,1994,84(5):1361-1392.
  • 6Isaacson P,Wright D,Ralfkiaer E,et al.Enteropathy-type T-cell lymphoma[M] //Jaffe ES,Harris NL,Stein H,et al.World Health Organization Classification of Tumours:Pathology and genetics.Lyon:IARC Press,2001:208-209.
  • 7Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of haemtopoietic and lymphoid tissues[M].4th ed.Lyon:International Agency for Research on Cancer,2008.
  • 8Isaacson P,Chott A,Ott G,et al.Enteropathy-associated T-cell lymphoma[M] //Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of haematopoietic and lymphoid tissue.4th ed.Lyon:IARC Press,2008:289-291.
  • 9Van de Water JM,Cillessen SA,Visser OJ,et al.Enteropathy associated T-cell lymphoma and its precursor lesions[J].Best Practice & Research Clinical Gastroenterology,2010,24:43-56.
  • 10Akiyama T,Okino T,Konishi H,et al.CD8t,CD56t (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy:clinicopathology and molecular study of five Japanese patients[J].Pathol Int,2008,58(10):626-634.

二级参考文献24

  • 1杨堤,白春梅,肖雨,陈杰.肠道原发性非霍奇金淋巴瘤32例的临床与病理学分析[J].中华病理学杂志,2004,33(5):445-448. 被引量:11
  • 2郑文,谢玉泉,朱军.外周T细胞淋巴瘤(非特指型)的诊断与治疗进展[J].中国肿瘤临床,2006,33(8):476-480. 被引量:10
  • 3黄慧强,彭玉龙,潘战和,蔡清清,林旭滨,蔡绮纯.CTOP与CHOP方案治疗外周T细胞淋巴瘤的疗效比较[J].中国肿瘤临床,2006,33(11):638-640. 被引量:10
  • 4赵静,易成.鼻和鼻型NK/T细胞淋巴瘤的治疗进展[J].中国肿瘤临床,2006,33(14):836-839. 被引量:14
  • 5刘卫平,Joostvan Gorp,李甘地,刘永惠,李俸媛,万红,Roel A de Weger.中线恶网中的EB病毒感染[J].中华肿瘤杂志,1997,19(1):49-52. 被引量:27
  • 6Lu D,lin CN,Chuang SS,et al.T-ceU and NX/T-cell lymphomas in southern Taiwan:a stuay of 72 cases in a single institute.Leuk Lymphoma,2004,45(5):923-928.
  • 7Kim K,Kim WS,Jung CW,et al.Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma(REAL)classification.Eur J Cancer,2002,38(1):75-81.
  • 8Arrowsmith ER,Macon WR,Kinney MC,et al.Peripheral T-cell lymphomas:clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.Leuk Lymphoma,2003,44(2):241-249.
  • 9de Campos ES,Menasce LP,Radford J,et al.Metastatic carcinoma of uncertain primary site:a retrospective review of 57 patients treated with vincristine,doxorubicin,cyclopnosphamide(VAC)or VAC alternating with cisplatin and etoposide(VAC/PE).Cancer,1994,73(2):470-475.
  • 10Buzzoni R,Colleoni M,Nelli P,et al.Results of a salvage regimen in refractory or relapsed non-Hodgkin s lymphoma.Leuk lymphoma,1994,14(1-2):121-128.

共引文献61

同被引文献33

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部